Introduction to Chronic Stable Angina
Coronary artery disease is a condition due to imbalance in oxygen demand and supply resulting predominantly from atherosclerotic disease of the coronary artery.
Its incidence is on the rise worldwide as a result of epidemiologic transition from communicable to non-communicable diseases.
Risk factors for Chronic Stable Angina
- Diabetes mellitus
- Hypertension
- Cigarette smoking
- Obesity
- Dyslipidaemia
- Advanced aging
- Male gender
Pathogenesis of Chronic Stable Angina
Atherosclerosis is the major underlying pathogenic factor (See diagram below)
Pathogenesis of Coronary artery disease
Epicardial coronary artery stenosis:
- 60% occlusion is compensated for at rest
- 60%-90% occlusion causes ischaemia when there is increased oxygen demand
- 90% occlusion results in ischaemia even at rest
Chronic stable angina (angina pectoris)
Clinical features
Symptoms
- Typically retrosternal chest pain or
heaviness worsened by exertion that radiates to the left upper arm
Angina equivalents include:
- Dyspnoea
- Palpitation
- Giddiness
- Fatigue
- Silent ischemia may occur in the diabetics & elderly
Signs
There may be no specific abnormal finding.
Nicotine stain of the nails and cardiomegaly may be observed
Differential diagnoses
- Pulmonary embolism
- Gastro-esophageal (GERD)
- Pericarditis
- Aortic dissection
- Mitral valve prolapse syndrome
- Esophageal spasm
- Costochondritis
Investigations
Resting ECG:
- Normal in 50% of patients
- ST depression
- May show Q wave of previous MI
Exercise stress ECG:
- Positive test evidenced by ST depression ≥ 1 mm (planar or down sloping)
- Arrhythmias or fall in BP
- Sensitivity (68%);
- Specificity (77%)
Echocardiography
Laboratory evaluation:
- Fasting Blood Glucose
- Lipid profile
- Electrolytes, urea & creatinine
Coronary angiography: Gold standard.
invasive, expensive & done only when
coronary artery bypass graft CABG or
angioplasty is planned.
Treatment for Coronary artery disease
Antipatelet therapy:
- Acetylsalicylic acid: 75 mg orally daily
Or:
- Clopidogrel 75 mg orally daily
Lipid lowering drugs:
- HMG-CoA reductase inhibitors
- Atovarstatin 10-20 mg orally daily
Nitrates:
- Short acting Glycerin Trinitrate tablets 0.3 – 1mg sublingually, repeated as required; 400
microgramspray/metered dose 1-2 doses under tongue
OR
- Intravenous infusion, 10-200
micrograms/minute, adjusted according to response; max. 400 micrograms/minute
Long acting Isosorbide dinitrate 30-120 mg three times daily, and up to 240 mg if required
Or
Intravenous infusion, 2-10 mg/hour, higher doses up to 20mg/hour may be required
Betablockers:
- Cardioselective (atenolol 50-100 mg
daily; metoprolol 50-200 mg daily). - Target pulse rate of 55-60 bpm
- Taper over 3-10 days
Calcium channel blockers
- Dihydropyridine
- Amlodipine 5-10 mg daily
Or:
-
- Nifedipine 20-60 mg daily
Or:
- Non-dihydropyridine:
- Verapamil 80-120 mg 8 hourly
Angiotensin converting enzyme inhibitor:
- Captopril 6.25 12.5 mg daily.
- Other ACEIs may be used in patients with hypertension
Angiotensin receptor blockers:
- Valsartan 80-160 mg daily
Revascularization:
- Percutaneous coronary intervention
- Coronary artery bypass graft